Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 361 to 364 of 364

Publication Record

Connections

The effect of somatostatin on glucose uptake and production by rat tissues in vitro.
Cherrington AD, Caldwell MD, Dietz MR, Exton JH, Crofford OB
(1977) Diabetes 26: 740-8
MeSH Terms: Adipose Tissue, Animals, Cyclic AMP, Dose-Response Relationship, Drug, Glucagon, Glucose, Hindlimb, In Vitro Techniques, Insulin, Liver, Male, Muscles, Protein Kinases, Rats, Somatostatin
Added December 10, 2013
0 Communities
1 Members
0 Resources
15 MeSH Terms
Studies on the role of cAMP-dependent protein kinase in the actions of glucagon and catecholamines on liver glycogen metabolism.
Cherrington AD, Exton JH
(1976) Metabolism 25: 1351-4
MeSH Terms: Animals, Cyclic AMP, Dose-Response Relationship, Drug, Epinephrine, Glucagon, Liver Glycogen, Phenylephrine, Phosphorylases, Protein Kinases, Rats, Receptors, Adrenergic
Show Abstract · Added December 10, 2013
Glucagon causes a rapid activation of cAMP-dependent protein kinase in rat liver parenchymal cells which correlates well with the accumulation of cAMP. Full activation of phosphorylase or inactivation of glycogen synthase is achieved with half-maximal or less activation of protein kinase. Epinephrine stimulates glycogen breakdown in these cells mainly by mechanisms involving alpha-adrenergic receptors and not beta-receptors. Activition of alpha-receptors results in rapid activation of phosphorylase and inactivation of glycogen synthase without accumulation of cAMP or activation of cAMP-dependent protein kinase. Activation of beta-receptors causes a transient rise in cAMP and a short-lived activation of protein kinase with correspondingly little stimulation of glycogenolysis.
0 Communities
1 Members
0 Resources
11 MeSH Terms
Persistent stimulatory effect of glucagon on glucose production despite downregulation.
Bloomgarden ZT, Liljenquist JE, Cherrington AD, Rabinowitz D
(1978) J Clin Endocrinol Metab 47: 1152-5
MeSH Terms: Adolescent, Adult, Blood Glucose, Glucagon, Glucose, Humans, Insulin, Male, Somatostatin
Show Abstract · Added December 10, 2013
The rise and subsequent return to basal of glucose production (Ra) during a constant glucagon infusion ("downregulation") has suggested to some workers that glucagon's effects are evanescent. To examine whether glucagon displays persistent biological activity even after downregulation, 6 healthy males received an 8 hour infusion of somatostatin and glucagon, with 3H-3-glucose to measure glucose turnover. Ra rose from 2.8 +/- 0.3 to 4.2 +/- 0.3 mg/kg . min at 90 minutes, returned to basal levels at 150 minutes, and remained at this level for the ensuing 330 minutes. Six additional subjects received an 8 hour somatostatin infusion, with glucagon administered concomitantly for the first 5 hours. Glucagon withdrawal at 5 hours produced an immediate decline in Ra from 1.8 +/- 0.2 to 0.9 +/- 0.2 mg/kg . min. Thus, even after downregulation the maintenance of basal Ra is dependent on circulating glucagon.
0 Communities
1 Members
0 Resources
9 MeSH Terms
Studies on the alpha-andrenergic activation of hepatic glucose output. II. Investigation of the roles of adenosine 3':5'-monophosphate and adenosine 3':5'-monophosphate-dependent protein kinase in the actions of phenylephrine in isolated hepatocytes.
Cherrington AD, Assimacopoulos FD, Harper SC, Corbin JD, Park CR, Exton JH
(1976) J Biol Chem 251: 5209-18
MeSH Terms: Adrenergic alpha-Agonists, Animals, Cyclic AMP, Enzyme Activation, Fluorides, Glucagon, Glucose, Liver, Magnesium, Osmolar Concentration, Phenoxybenzamine, Phenylephrine, Potassium Chloride, Propranolol, Protein Kinases, Rats, Xanthines
Show Abstract · Added December 10, 2013
The effects of the alpha-adrenergic agonist phenylephrine on the levels of adenosine 3':5'-monophosphate (cAMP) and the activity of the cAMP-dependent protein kinase in isolated rat liver parenchymal cells were studied. Cyclic AMP was very slightly (5 to 13%) increased in cells incubated with phenylephrine at a concentration (10(-5) M) which was maximally effective on glycogenolysis and gluconeogenesis. However, the increase was significant only at 5 min. Cyclic AMP levels with 10(-5) M phenylephrine measured at this time were reduced by the beta-adrenergic antagonist propranolol, but were unaffected by the alpha-blocker phenoxybenzamine, indicating that the elevation was due to weak beta activity of the agonist. When doses of glucagon, epinephrine, and phenylephrine which produced the same stimulation of glycogenolysis or gluconeogenesis were added to the same batches of cells, there were marked rises in cAMP with glucagon, minimal increases with epinephrine, and little or no changes with phenylephrine, indicating that the two catecholamine stimulated these processes largely by mechanisms not involving cAMP accumulation. DEAE-cellulose chromatography of homogenates of liver cells revealed two major peaks of cAMP-dependent protein kinase activity. These eluted at similar salt concentrations as the type I and II isozymes from rat heart. Optimal conditions for preservation of hormone effects on the activity of the enzyme in the cells were determined. High concentrations of phenylephrine (10(-5) M and 10(-4) M) produced a small increase (10 tp 16%) in the activity ratio (-cAMP/+cAMP) of the enzyme. This was abolished by propranolol, but not by phenoxybenzamine, indicating that it was due to weak beta activity of the agonist. The increase in the activity ratio of the kinase with 10(-5) M phenylephrine was much smaller than that produced by a glycogenolytically equivalent dose of glucagon. The changes in protein kinase induced by phenylephrine and the blockers and by glucagon were thus consistent with those in cAMP. Theophylline and 1-methyl-3-isobutylxanthine, which inhibit cAMP phosphodiesterase, potentiated the effects of phenylephrine on glycogenolysis and gluconeogenesis. The potentiations were blocked by phenoxybenzamine, but not by propranolol. Methylisobutylxanthine increased the levels of cAMP and enhanced the activation of protein kinase in cells incubated with phenylephrine. These effects were diminished or abolished by propanolol, but were unaffected by phenoxybenzamine. It is concluded from these data that alpha-adrenergic activation of glycogenolysis and gluconeogenesis in isolated rat liver parenchymal cells occurs by mechanisms not involving an increase in total cellular cAMP or activation of the cAMP-dependent protein kinase. The results also show that phosphodiesterase inhibitors potentiate alpha-adrenergic actions in hepatocytes mainly by a mechanism(s) not involving a rise in cAMP.
0 Communities
1 Members
0 Resources
17 MeSH Terms